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a b s t r a c t
Camptocormia is a postural affl iction characterised by abnormal fl exion of the thoraco-
lumbar spine, which appears upon standing, increases with walking, and disappears in the 
supine position. Only fi ve cases of camptocormia secondary to idiopathic infl ammatory 
myopathies have been described in the literature. In this case report, we describe the case 
of a male patient 67 years of age who suffered from polymyositis for 18 years, which was 
associated with manifestations compatible with camptocormia. The clinical manifesta-
tions were stable and did not progress. Polymyositis is an idiopathic infl ammatory myopa-
thy clinically characterised by symmetric weakness that predominantly affects the proxi-
mal muscles. Nevertheless, polymyositis is a systemic autoimmune disease; therefore, the 
skeletal muscles may be diffusely affected, including the paravertebral muscles, which may 
manifest as camptocormia.
© 2013 Elsevier Editora Ltda. All rights reserved.
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r e s u m o
A camptocormia é uma doença postural caracterizada por fl exão anormal da coluna to-
racolombar que surge na posição ereta, aumenta durante a caminhada e desaparece na 
posição supina. Na literatura, há descrição de apenas cinco casos de camptocormia secun-
dária a miopatias infl amatórias idiopáticas. No presente relato de caso, descrevemos um 
paciente do sexo masculino, de 67 anos, com polimiosite há 18 anos, cursando com quadro 
compatível com camptocormia (estável e sem progressão do quadro clínico). A polimiosite 
é uma miopatia infl amatória idiopática caracterizada clinicamente por fraqueza muscu-
lar simétrica predominantemente proximal dos membros. Entretanto, sendo uma doença 
autoimune sistêmica, é plausível que ocorra acometimento de musculatura esquelética de 
forma difusa, incluindo a paravertebral, podendo manifestar-se com camptocormia.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
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Introduction
Camptocormia [(Greek: kamptos (to bend) and kormos 
(trunk)] is a postural disorder characterised by abnormal fl ex-
ion of the thoracolumbar spine, which appears upon stand-
ing, increases with walking, and disappears in the supine po-
sition.1 Camptocormia was fi rst described in 18182 and was 
initially considered to be a psychogenic disorder because the 
fi rst cases were observed in soldiers during World War I. This 
condition was considered to be a conversion disorder.1 Sub-
sequently, new cases were described and in addition to psy-
chiatric disorders, several musculoskeletal and neurological 
conditions were implicated in the aetiology of this disease.3-11 
Camptocormia is an uncommon condition, and only fi ve cas-
es of camptocormia secondary to idiopathic infl ammatory 
myopathies have been described.10,11
In this report, we present the case of a patient with camp-
tocormia and polymyositis, which provides further evidence 
of an association between these two rare conditions. 
Case report
An Asian male 67 years of age who was residing in São Paulo 
presented with an insidious and chronic history of progres-
sive proximal muscle weakness that affected all four limbs 
(mainly the lower limbs) and the thoracolumbar area. No con-
stitutional symptoms were observed, and there was no ap-
parent cause. The patient had been followed up at another 
healthcare service centre, and he could not name the exact 
medications that he had used. 
The patient fi rst consulted our clinic 10 years after the 
onset of symptoms. Upon physical examination, the patient 
exhibited objective proximal muscle weakness that affected 
the lower limbs (muscle strength grade IV), whereas the up-
per limbs exhibited muscle strength grade V. In the supine po-
sition, he exhibited signifi cant thoracolumbar kyphosis, and 
the hip was placed forward to correct the centre of gravity. 
Those alterations increased with walking and disappeared in 
the dorsal decubitus position. The patient further exhibited 
hypotrophy of the paravertebral muscles. A radiological ex-
amination failed to fi nd vertebral fractures or signs of spinal 
kyphosis or lordosis. Laboratory testing revealed that the se-
rum creatine kinase concentration was 1,103 IU/L (reference 
values: 24-173 IU/L), and the aldolase concentration was 6.0 
IU/L (reference values: 1.0-7.5 IU/L). A biopsy of the biceps 
muscle indicated perimysial lymphomononuclear infl am-
matory infi ltrate and sparse degenerated and necrotic fi bres 
with infi ltrating macrophages, which suggested a diagnosis 
of infl ammatory myopathy. Electroneuromyography showed 
signals of proximal infl ammatory myopathy in all four limbs. 
A diagnosis of polymyositis and associated camptocormia 
was established. The oral corticosteroid dose was optimised 
(prednisone 1 mg/kg/day) and combined fi rst with azathio-
prine (maximum dose 150 mg/day); subsequently, methotrex-
ate (maximum dose 25 mg/week) and cyclosporine (maximum 
dose 100 mg/day) to avoid the chronic use of corticosteroids. 
In addition, physical therapy was indicated, including exer-
cises to strengthen the thoracolumbar area. 
The patient has now been followed up for eight years as 
an outpatient. The clinical and laboratory manifestations are 
stable and have not increased; however, several sequelae have 
remained (weakness of the lower limbs and signifi cant thora-
columbar kyphosis with the anterior position of the hip). The 
serum creatine kinase concentration was approximately 200 
U/L, and the aldolase concentration was approximately 6.0 
U/L. The patient uses methotrexate 20 mg/week and azathio-
prine 100 mg/day. Magnetic resonance imaging (MRI) of the 
thoracolumbar area showed signifi cant replacement of the 
lumbar paravertebral muscles by fatty tissue (Fig. 1). 
Discussion
In this report, we describe the case of a patient with poly-
myositis and associated camptocormia. Polymyositis is an id-
iopathic infl ammatory myopathy clinically characterised by 
symmetric weakness that predominantly affects the proxi-
mal muscles. Polymyositis is a systemic autoimmune illness; 
therefore, the skeletal muscles may be diffusely affected, in-
cluding the paravertebral muscles. From a clinical perspec-
tive, this diffuse muscle weakness destabilises the postural 
tone, which results in dorsifl exion of the cervical and/or 
thoracolumbar areas. The abnormal posture becomes worse 
with walking and disappears in the supine position. Campto-
cormia is characterised by these clinical manifestations. MRI 
may show signs of atrophy and replacement of the paraver-
tebral muscles by fat,12,13 which were observed in this case. 
Electroneuromyographic fi ndings are not uniform and may 
be consistent with both myogenic and neurogenic features.14
Only fi ve cases of camptocormia associated with infl am-
matory myopathies have been documented. Kuo et al.10 de-
scribed the fi rst case of camptocormia associated with in-
fl ammatory myopathy. In that patient, the posture disorder 
was present when the autoimmune muscle disease was di-
agnosed. The patient was a female who was treated with par-
enteral pulse methylprednisolone, which slightly improved 
muscle strength and posture. Delcey et al.11 reported a series 
Fig. 1 – Magnetic resonance imaging of the thoracolumbar 
area shows signifi cant replacement of the paravertebral 
muscles by fat in the lumbar area. (A) A sagittal T1 scan 
and (B) an axial T2 scan show a remarkable increase in 
adipose tissue in the paravertebral muscles characterised 
by increased signal intensity in the T1 and T2 images. Rare 
remaining fi bres are represented by thin isosignal lines. 
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of seven cases of camptocormia, four of which exhibited der-
matomyositis/polymyositis. The patients were subjected to 
corticoid therapy, human intravenous immunoglobulin, or 
cyclosporine, which improved camptocormia in three cases. 
The patient in our study had a chronic history of polymyositis 
and associated camptocormia, which negatively affected his 
quality of life. 
The therapeutic options for camptocormia are limited and 
often poorly effective. The treatment choices include con-
trolling the primary disease, the use of orthoses, and physi-
cal therapy. Improvement has been reported after treatment 
with corticosteroids and human immunoglobulin in cases of 
camptocormia secondary to infl ammatory myopathy.15 In this 
study, despite the stabilisation of the myopathy, the treat-
ment did not improve the manifestations of camptocormia. 
Therefore, camptocormia may be considered a sequela of the 
original myopathy that might have been avoided by the early 
institution of aggressive treatment. 
In summary, infl ammatory myopathies are systemic dis-
eases; therefore, the skeletal muscles may be affected, includ-
ing the paravertebral muscles at the lumbosacral spine, with 
consequential biomechanical repercussions. In the present 
case, camptocormia may be considered a biomechanical con-
sequence of paravertebral muscle weakness. 
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